BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 16647356)

  • 1. Ex vivo sentinel lymph node mapping in colon cancer: improving the accuracy of pathologic staging?
    Smith J; Hwang H; Wiseman KW; Filipenko D; Phang PT
    Am J Surg; 2006 May; 191(5):665-8. PubMed ID: 16647356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node evaluation does not improve staging accuracy in colon cancer.
    Lim SJ; Feig BW; Wang H; Hunt KK; Rodriguez-Bigas MA; Skibber JM; Ellis V; Cleary K; Chang GJ
    Ann Surg Oncol; 2008 Jan; 15(1):46-51. PubMed ID: 17985187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mapping the sentinel lymph node ex vivo and finding the micrometastasis by CK-immunostaining in carcinoma of the colon and rectum].
    Wang FL; Pan ZZ; Wan DS
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):994-7. PubMed ID: 16194357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01.
    Stojadinovic A; Nissan A; Protic M; Adair CF; Prus D; Usaj S; Howard RS; Radovanovic D; Breberina M; Shriver CD; Grinbaum R; Nelson JM; Brown TA; Freund HR; Potter JF; Peretz T; Peoples GE
    Ann Surg; 2007 Jun; 245(6):846-57. PubMed ID: 17522508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of sentinel node mapping for cancer of the colon: 'to map or not to map".
    Thomas KA; Lechner J; Shen P; Waters GS; Geisinger KR; Levine EA
    Am Surg; 2006 Jul; 72(7):606-11; discussion 611-2. PubMed ID: 16875082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo sentinel lymph node mapping in laparoscopic resection of colon cancer.
    Rivet EB; Mutch MG; Ritter JH; Khan AA; Lewis JS; Winslow E; Fleshman JW
    Colorectal Dis; 2011 Nov; 13(11):1249-55. PubMed ID: 21083799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical application of sentinel lymph node biopsy for staging, treatment and prognosis of colon and gastric cancer.
    Dragan R; Nebojsa M; Dejan S; Ivan P; Dragos S; Damir J; Predrag S; Vladan Z
    Hepatogastroenterology; 2009; 56(96):1606-11. PubMed ID: 20214202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo sentinel lymph node mapping in patients undergoing proctectomy for rectal cancer.
    Finan KR; Lewis JS; Winslow E; Mutch MG; Birnbaum EH; Fleshman JW
    Dis Colon Rectum; 2010 Mar; 53(3):243-50. PubMed ID: 20173468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative RT-PCR detection of tumor cells in sentinel lymph nodes isolated from colon cancer patients with an ex vivo approach.
    Nordgård O; Oltedal S; Kørner H; Aasprong OG; Tjensvoll K; Gilje B; Heikkilä R
    Ann Surg; 2009 Apr; 249(4):602-7. PubMed ID: 19300229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
    Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
    J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective multicenter trial of staging adequacy in colon cancer: preliminary results.
    Bilchik AJ; DiNome M; Saha S; Turner RR; Wiese D; McCarter M; Hoon DS; Morton DL
    Arch Surg; 2006 Jun; 141(6):527-33; discussion 533-4. PubMed ID: 16785352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel node mapping in colon carcinoma: in-vivo versus ex-vivo approach.
    Tuech JJ; Pessaux P; Di Fiore F; Nitu V; Lefebure B; Colson A; Michot F
    Eur J Surg Oncol; 2006 Mar; 32(2):158-61. PubMed ID: 16376515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ex vitro sentinel lymph node mapping in colorectal carcinoma].
    Chen DJ; Zhou FQ; Gan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):124-6. PubMed ID: 16555150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel node staging in colon carcinoma: value of sentinel lymph node biopsy with radiocolloid and blue staining.
    Terwisscha Van Scheltinga SE; Den Boer FC; Pijpers R; Meyer GA; Engel AF; Silvis R; Meijer S; van der Sijp JR
    Scand J Gastroenterol Suppl; 2006; (243):153-7. PubMed ID: 16782635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
    Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
    J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001.
    Redston M; Compton CC; Miedema BW; Niedzwiecki D; Dowell JM; Jewell SD; Fleshman JM; Bem J; Mayer RJ; Bertagnolli MM;
    J Clin Oncol; 2006 Feb; 24(6):878-83. PubMed ID: 16418493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial.
    Bilchik AJ; Hoon DS; Saha S; Turner RR; Wiese D; DiNome M; Koyanagi K; McCarter M; Shen P; Iddings D; Chen SL; Gonzalez M; Elashoff D; Morton DL
    Ann Surg; 2007 Oct; 246(4):568-75; discussion 575-7. PubMed ID: 17893493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
    Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
    Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy.
    Alran S; De Rycke Y; Fourchotte V; Charitansky H; Laki F; Falcou MC; Benamor M; Freneaux P; Salmon RJ; ; Sigal-Zafrani B
    Ann Surg Oncol; 2007 Aug; 14(8):2195-201. PubMed ID: 17294071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.